Was this the right medication
According to new recommendations from cognitive behavior therapy for BED, GLP-1RAs may be cautiously considered in patients with clinical obesity who do not overvalue shape and weight, have no history of anorexia nervosa or bulimia nervosa, and who have already made progress in adopting regular eating patterns and reducing binge-eating episodes
Its approval was based on four of the randomised, double-blind, placebo-controlled phase III trials from the Semaglutide Treatment Effect in People with Obesity (STEP) programme conducted among approximately 5000 patients [7,8,9,10]
Several doctors interviewed by TODAY.com believe semaglutide needs to be taken for years, decades or possibly life
Mut, mutation
Semaglutide increases the use of stored fat for energy, helping promote weight loss